Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine for Postoperative Analgesia and Recovery
NCT06409689Recruiting
- Sponsor
- Tongji Hospital
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of oliceridine in postoperative pain (4 arms), sponsored by Tongji Hospital. Primary endpoint: Postoperative Pain Score (NRS) at 48 hours. Started Jun 2024; status: recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06409689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06409689.